GPhA's New CEO Ralph Neas Brings Health Reform Advocacy Experience
This article was originally published in The Pink Sheet Daily
After 14-month vacancy, GPhA fills its top post with National Coalition on Health Care CEO Ralph Neas, who offers coalition-building skills and long background in civil rights political work.
You may also be interested in...
The generic drug trade association’s cross-cutting priorities are the result of an extensive strategic planning process, CEO Ralph Neas says; the group is planning outreach to Congress and the executive branch to highlight the role generic drugs can play in helping to address the nation’s fiscal problems.
It may be a best-case scenario for the biopharmaceutical industry if the Joint Select Committee on Deficit Reduction is unable to produce a proposal by Thanksgiving to cut the federal deficit by at least $1.2 trillion over 10 years.
The Senate will vote on whether to limit debate on the House-passed patent reform bill when it reconvenes on Sept. 6. Senate Majority Leader Harry Reid, D-Nev., made a motion for the cloture vote before the August recess in hopes of getting a final bill through Congress quickly.